Pain and MS

International MS Journal

Volumn 10, Issue 1, 2003, Pages 14-19

  Solaro, C ^a   Lunardi, G L ^b   Mancardi, G L ^c,d  

^a PA Micone Hospital   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d NONE   (Italy)

Author keywords

Classification; Dysaesthesla; Multiple sclerosis; Pain; Symptoms; Therapy; Trigeminal neuralgia

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE;

ATAXIA; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSESTHESIA; EYE MOVEMENT DISORDER; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; REVIEW; SKIN MANIFESTATION; SOMNOLENCE; TRIGEMINUS NEURALGIA; VERTIGO;

HUMANS; MULTIPLE SCLEROSIS; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX;

EID: 0037695065     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Merskey H (ed). An Investigation of Pain in Psychological Illness. Oxford: Oxford University Press, 1964.
2. Warnell P. The pain experience of a multiple sclerosis population: a descriptive study. Axone 1991; 13: 26-28.
3. Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 1994; 58: 89-93.
4. Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology 1988; 38: 1830-1834.
5. Kanner RM. Treatment of chronic pain. In: Multiple Sclerosis Therapeutics (Rudick AR, Goodkin DE, eds). Ohio: Martin Dunitz Ltd, 1999; pp541-546.
6. Attal N, Bouhassira D. Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand Suppl 1999; 173: S12-S24.
7. Devor M. Pathophysiology of damaged nerves in relation to chronic pain. In: Textbook of Pain (Wall PD, Melzack R, eds). New York: Churchill Livingstone, 1999; pp129-164.
8. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-227.
9. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet 1999; 353: 1959-1964.
10. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995; 45: 1294-1296.
11. Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 1997; 49: 1142-1144.
12. Cruccu G, Leandri M, Feliciani M, Manfredi M. Idiopathic and symptomatic trigeminal pain. J Neurol Neurosurg Psychiatry 1990; 53: 1034-1042.
13. Hutchins LG, Harnsberger HR, Jacobs JM, Apfelbaum RI. Trigeminal neuralgia (tic douloureux): MR imaging assessment. Radiology 1990; 175: 837-841.
14. Espir ML, Millac P. Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J Neurol Neurosurg Psychiatry 1970; 33: 528-531.
15. Ramsaransing G, Zwanikken C, De Keyser J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. BMJ 2000; 320: 1113.
16. Leandri M, Lundardi G, Inglese M, Messmer-Uccelli M, Mancardi GL, Gottlieb A et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol 2000; 247: 556-558.
17. Lunardi G, Leandri M, Albano C, Cultrera S, Fracassi M, Rubino V et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997; 48: 1714-1717.
18. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998; 51: 611-614.
19. Solaro C, Lunardi GL, Capello E, Inglese M, Messmer Uccelli M, Uccelli A et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998; 51: 609-611.
20. Reder AT, Arnason BG. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 1995; 45: 1097-1100.
21. Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL. Low-close gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 2000; 44: 45-48.
22. Leandri M, Gottlieb A. Trigeminal evoked potential-monitors thermorhizotomy: a novel approach of relief of trigeminal pain. J Neurosurg 1996; 84: 929-939.
23. Broggi G, Ferroli P, Franzini A, Pluderi M, La Mantia L, Milanese C. Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet 1999; 354: 1878-1879.
24. Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch Neurol 1984; 41: 1270-1272.
25. Vermote R, Ketelaer P, Carton H. Pain in multiple sclerosis patients. A prospective study using the Mc Gill Pain Questionnaire. Clin Neurol Neurosurg 1996; 88: 87-93.
26. Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. A 5 year follow up study. Ital J Neurol Sci 1995; 16: 529-532.
27. Tremont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 2000; 60: 1029-1052.
28. Cianchetti C, Zuddas A, Randazzo AP, Perra L, Marrosu MG. Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations. Neurology 1999; 53: 433.
29. Houtchens MK, Richert JR, Sami A, Rose JW. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler 1997; 3: 250-253.
30. McQuay H. Opioids in chronic non malignant pain. BMJ 2001; 322: 1134-1135.
31. Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult Scler 2000; 6: 192-193.